"Routine clopidogrel pretreatment before elective coronary angiography is not justified"

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1604, 2007-01, pp. : 6-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Impact of genetic variants on post-clopidogrel platelet reactivity in patients after elective percutaneous coronary intervention

By Rideg Orsolya Komócsi András Magyarlaki Tamás Tőkés-Füzesi Margit Miseta Attila Kovács Gábor L Aradi Dániel

Pharmacogenomics, Vol. 12, Iss. 9, 2011-09 ,pp. : 1269-1280

Future Medicine

Access to resources Recommend Favorite

The benefits of abciximab questioned in percutaneous coronary interventions following pretreatment with high-dose clopidogrel

By Salam Amar Mohammad

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 3, 2005-03 ,pp. : 335-338

Informa Healthcare

Access to resources Recommend Favorite

Clopidogrel an alternative to ticlopidine in coronary stenting

Inpharma, Vol. 1, Iss. 1223, 2000-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Clopidogrel: a CURE in acute coronary syndromes?

By Doggrell Sheila A

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 3, 2002-03 ,pp. : 351-353

Informa Healthcare

Access to resources Recommend Favorite

Clopidogrel Resistance: Implications for Coronary Stenting

Current Pharmaceutical Design, Vol. 12, Iss. 10, 2006-04 ,pp. : 1261-1269

Bentham Science Publishers

Access to resources Recommend Favorite